Advertisement

Reactions Weekly

, Volume 1778, Issue 1, pp 40–40 | Cite as

Anaplastic lymphoma kinase inhibitors: case report

Multiple drug resistance: case report
Case report

Reference

  1. Ouseph MM, et al. TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Lung Cancer: Targets and Therapy 10: 81-86, 15 Aug 2019. Available from: URL: http://doi.org/10.2147/LCTT.S212406 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations